Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly

Applied Microbiology and Biotechnology

Volumn 99, Issue 15, 2015, Pages 6351-6361

  Kuthning, Anja ^a   Mösker, Eva ^a   Süssmuth, Roderich D ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Genetic engineering; Heterologous expression; Lantibiotic; Lichenicidin; Synthetic biology

Indexed keywords

ANTIBIOTICS; BACTERIOLOGY; BIOCHEMISTRY; CLONING; ESCHERICHIA COLI; GENETIC ENGINEERING;

BACILLUS LICHENIFORMIS; HETEROLOGOUS EXPRESSION; LANTIBIOTICS; LICHENICIDIN; MUTAGENESIS EXPERIMENT; PEPTIDE ENGINEERINGS; PHARMACEUTICAL APPLICATIONS; SYNTHETIC BIOLOGY;

PEPTIDES;

LANTIBIOTIC; BACTERIOCIN; RECOMBINANT PROTEIN;

AMINO ACID; ANTIBIOTICS; BACTERIUM; CLONE; GENE EXPRESSION; GENETIC ENGINEERING; PEPTIDE; PLASMID;

ARTICLE; BACILLUS LICHENIFORMIS; CLONING; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CLUSTER; GENETIC ENGINEERING; HETEROLOGOUS EXPRESSION; NONHUMAN; PEPTIDE SYNTHESIS; PROMOTER REGION; PROTEIN EXPRESSION; STRUCTURAL GENE; SYNTHETIC BIOLOGY; GENE EXPRESSION; GENETICS; METABOLIC ENGINEERING; METABOLISM; MOLECULAR CLONING; PLASMID; PROCEDURES;

BACILLUS LICHENIFORMIS; ESCHERICHIA COLI; NEGIBACTERIA;

BACTERIOCINS; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION; METABOLIC ENGINEERING; METABOLIC NETWORKS AND PATHWAYS; PLASMIDS; RECOMBINANT PROTEINS;

EID: 84937641920     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6557-6     Document Type: Article

References (51)

1. Andersson L, Blomberg L, Flegel M, Lepsa L, Nilsson B, Verlander M (2000) Large-scale synthesis of peptides. Pept Sci 55:227–250. doi:10.1002/1097-0282(2000)55:3<227::AID-BIP50>3.0.CO;2-7
2. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian K-D, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJT, Rebuffat S, Ross RP, Sahl H-G, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang G-L, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA (2012) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108–160. doi:10.1039/C2NP20085F
3. Aso Y, Nagao J-I, Koga H, Okuda K-I, Kanemasa Y, Sashihara T, Nakayama J, Sonomoto K (2004) Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. J Biosci Bioeng 98:429–436. doi:10.1016/S1389-1723(05)00308-7
4. Berrow NS, Büssow K, Coutard B, Diprose J, Ekberg M, Folkers GE, Levy N, Lieu V, Owens RJ, Peleg Y, Pinaglia C, Quevillon-Cheruel S, Salim L, Scheich C, Vincentelli R, Busso D (2006) Recombinant protein expression and solubility screening in Escherichia coli: a comparative study. Acta Crystallogr D Biol Crystallogr 62:1218–1226. doi:10.1107/S0907444906031337
5. Blommel PG, Becker KJ, Duvnjak P, Fox BG (2007) Enhanced bacterial protein expression during auto-induction obtained by alteration of Lac repressor dosage and medium composition. Biotechnol Prog 23:585–598. doi:10.1021/bp070011x
6. Caetano T, Krawczyk JM, Mösker E, Süssmuth RD, Mendo S (2011a) Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol 18:90–100. doi:10.1016/j.chembiol.2010.11.010
7. Caetano T, Krawczyk JM, Mosker E, Sussmuth RD, Mendo S (2011b) Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection. Appl Environ Microbiol 77:5023–5026. doi:10.1128/AEM. 00270-11
8. Cao W, Zhou Y, Ma Y, Luo Q, Wei D (2005) Expression and purification of antimicrobial peptide adenoregulin with C-amidated terminus in Escherichia coli. Protein Expr Purif 40:404–410. doi:10.1016/j.pep.2004.12.007
9. Chatterjee C, Paul M, Xie L, van der Donk WA (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105:633–684. doi:10.1021/cr030105v
10. Chatterjee A, Xiao H, Schultz PG (2012) Evolution of multiple, mutually orthogonal prolyl-tRNA synthetase/tRNA pairs for unnatural amino acid mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A 109:14841–14846. doi:10.1073/pnas.1212454109
11. Chiang Y-M, Oakley CE, Ahuja M, Entwistle R, Schultz A, Chang S-L, Sung CT, Wang CCC, Oakley BR (2013) An efficient system for heterologous expression of secondary metabolite genes in Aspergillus nidulans. J Am Chem Soc 135:7720–7731. doi:10.1021/ja401945a
12. Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81:136–147. doi:10.1111/cbdd.12055
13. Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E (1999) Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp. Eur J Biochem FEBS 266:335–346
14. Ferir G, Petrova MI, Andrei G, Huskens D, Hoorelbeke B, Snoeck R, Vanderleyden J, Balzarini J, Bartoschek S, Bronstrup M, Sussmuth RD, Schols D (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One. doi:10.1371/journal.pone.0064010
15. Gutierrez J, Criado R, Martin M, Herranz C, Cintas LM, Hernandez PE (2005) Production of enterocin P, an antilisterial pediocin-like bacteriocin from Enterococcus faecium P13, in Pichia pastoris. Antimicrob Agents Chemother 49:3004–3008. doi:10.1128/AAC. 49.7.3004-3008.2005
16. Ikram N, Naz S, Rajoka MI, Sadaf S, Akhtar MW (2009) Enhanced production of subtilisin of Pyrococcus furiosus expressed in Escherichia coli using autoinducing medium. Afr J Biotechnol. doi:10.4314/ajb.v8i21.66064
17. Ingham AB, Moore RJ (2007) Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47:1–9. doi:10.1042/BA20060207
18. Jaitzig J, Li J, Süssmuth RD, Neubauer P (2013) Reconstituted biosynthesis of the nonribosomal macrolactone antibiotic valinomycin in Escherichia coli. ACS Synth Biol. doi:10.1021/sb400082j
19. Jones AM, Helm JM (2009) Emerging treatments in cystic fibrosis. Drugs 69:1903–1910. doi:10.2165/11318500-000000000-00000
20. Karakas-Sen A, Narbad A (2012) Heterologous expression and purification of NisA, the precursor peptide of lantibiotic nisin from Lactococcus lactis. Acta Biol Hung 63:301–310. doi:10.1556/ABiol.63.2012.2.11
21. Knappe TA, Linne U, Zirah S, Rebuffat S, Xie X, Marahiel MA (2008) Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264. J Am Chem Soc 130:11446–11454. doi:10.1021/ja802966g
22. Kodani S, Lodato MA, Durrant MC, Picart F, Willey JM (2005) SapT, a lanthionine-containing peptide involved in aerial hyphae formation in the streptomycetes. Mol Microbiol 58:1368–1380. doi:10.1111/j.1365-2958.2005.04921.x
23. Li Y, Chen Z (2008) RAPD: a database of recombinantly-produced antimicrobial peptides. FEMS Microbiol Lett 289:126–129. doi:10.1111/j.1574-6968.2008.01357.x
24. Li Z, Kessler W, van den Heuvel J, Rinas U (2011) Simple defined autoinduction medium for high-level recombinant protein production using T7-based Escherichia coli expression systems. Appl Microbiol Biotechnol 91:1203–1213. doi:10.1007/s00253-011-3407-z
25. Li J, Jaitzig J, Hillig F, Süssmuth R, Neubauer P (2014) Enhanced production of the nonribosomal peptide antibiotic valinomycin in Escherichia coli through small-scale high cell density fed-batch cultivation. Appl Microbiol Biotechnol 98:591–601. doi:10.1007/s00253-013-5309-8
26. Lin PF, Samanta H, Bechtold CM, Deminie CA, Patick AK, Alam M, Riccardi K, Rose RE, White RJ, Colonno RJ (1996) Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor. Antimicrob Agents Chemother 40:133–138
27. Matthes D, Richter L, Müller J, Denisiuk A, Feifel SC, Xu Y, Espinosa-Artiles P, Süssmuth RD, Molnár I (2012) In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues. Chem Commun 48:5674–5676. doi:10.1039/C2CC31669B
28. Meindl K, Schmiederer T, Schneider K, Reicke A, Butz D, Keller S, Gühring H, Vértesy L, Wink J, Hoffmann H, Brönstrup M, Sheldrick GM, Süssmuth RD (2010) Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed 49:1151–1154. doi:10.1002/anie.200905773
29. Mendo SA, Henriques IS, Correia AC, Duarte JM (2000) Genetic characterization of a new thermotolerant Bacillus licheniformis strain. Curr Microbiol 40:137–139
30. Mendo S, Faustino NA, Sarmento AC, Amado F, Moir AJG (2004) Purification and characterization of a new peptide antibiotic produced by a thermotolerant Bacillus licheniformis strain. Biotechnol Lett 26:115–119
31. Nagao J, Harada Y, Shioya K, Aso Y, Zendo T, Nakayama J, Sonomoto K (2005) Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Biochem Biophys Res Commun 336:507–513. doi:10.1016/j.bbrc.2005.08.125
32. Nakamura M, Saeki K, Takahashi Y (1999) Hyperproduction of recombinant ferredoxins in Escherichia coli by coexpression of the ORF1-ORF2-iscS-iscU-iscA-hscB-hs cA-fdx-ORF3 gene cluster. J Biochem (Tokyo) 126:10–18
33. Nehring S, Budisa N, Wiltschi B (2012) Performance analysis of orthogonal pairs designed for an expanded eukaryotic genetic code. PLoS One 7:e31992. doi:10.1371/journal.pone.0031992
34. Oldach F, Al Toma R, Kuthning A, Caetano T, Mendo S, Budisa N, Süssmuth RD (2012) Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew Chem Int Ed 51:415–418. doi:10.1002/anie.201106154
35. Oman TJ, van der Donk WA (2009) Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem Biol 4:865–874. doi:10.1021/cb900194x
36. Ongley SE, Bian X, Neilan BA, Müller R (2013) Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat Prod Rep 30:1121–1138. doi:10.1039/C3NP70034H
37. Parachin NS, Mulder KC, Viana AAB, Dias SC, Franco OL (2012) Expression systems for heterologous production of antimicrobial peptides. Peptides 38:446–456. doi:10.1016/j.peptides.2012.09.020
38. Rohrlack T, Christoffersen K, Kaebernick M, Neilan BA (2004) Cyanobacterial protease inhibitor microviridin J causes a lethal molting disruption in Daphnia pulicaria. Appl Environ Microbiol 70:5047–5050. doi:10.1128/AEM. 70.8.5047-5050.2004
39. Sakai K, Kinoshita H, Shimizu T, Nihira T (2008) Construction of a citrinin gene cluster expression system in heterologous Aspergillus oryzae. J Biosci Bioeng 106:466–472
40. Sambrook J, Fritsch EF, Maniatis T (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
41. Sanchez J, Borrero J, Gomez-Sala B, Basanta A, Herranz C, Cintas LM, Hernandez PE (2008) Cloning and heterologous production of hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in Lactic acid Bacteria and Pichia pastoris. Appl Environ Microbiol 74:2471–2479. doi:10.1128/AEM. 02559-07
42. Scholz R, Molohon KJ, Nachtigall J, Vater J, Markley AL, Süssmuth RD, Mitchell DA, Borriss R (2011) Plantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42. J Bacteriol 193:215–224. doi:10.1128/JB.00784-10
43. Selzer G, Som T, Itoh T, Tomizawa J (1983) The origin of replication of plasmid p15A and comparative studies on the nucleotide sequences around the origin of related plasmids. Cell 32:119–129. doi:10.1016/0092-8674(83)90502-0
44. Shi Y, Yang X, Garg N, van der Donk WA (2011) Production of lantipeptides in Escherichia coli. J Am Chem Soc 133:2338–2341. doi:10.1021/ja109044r
45. Shi Y, Bueno A, van der Donk WA (2012) Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli. Chem Commun 48:10966–10968. doi:10.1039/C2CC36336D
46. Steiner T, Hess P, Bae JH, Wiltschi B, Moroder L, Budisa N (2008) Synthetic biology of proteins: tuning GFPs folding and stability with fluoroproline. PLoS One. doi:10.1371/journal.pone.0001680
47. Studier FW (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41:207–234
48. Van Reenen CA, Chikindas ML, Van Zyl WH, Dicks LMT (2003) Characterization and heterologous expression of a class IIa bacteriocin, plantaricin 423 from Lactobacillus plantarum 423, in Saccharomyces cerevisiae. Int J Food Microbiol 81:29–40
49. Watanabe K, Praseuth AP, Praseuth MB, Hotta K (2009) Chapter 15 plasmid-borne gene cluster assemblage and heterologous biosynthesis of nonribosomal peptides in Escherichia coli. In: Hopwood DA (ed) Methods Enzymol. Academic Press, pp 379–399
50. Zhang H, Wang Y, Wu J, Skalina K, Pfeifer BA (2010) Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem Biol 17:1232–1240. doi:10.1016/j.chembiol.2010.09.013
51. Zhu B, Cai G, Hall EO, Freeman GJ (2007) In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors and mutations. Biotechniques 43:354–359